New Call for UK to Reform First-in-Man Clinical Trials
A new report by the UK’s Royal Statistical Society (RSS) proposes sweeping reforms aimed at minimizing the risk to volunteers in drug trials, maximizing design efficiency and enhancing scrutiny of clinical trial protocols.
This article is viewable by subscribers only. To view this article, please select an option below.